TY  - JOUR
AU  - Marqués, Miriam
AU  - Corral, Sonia
AU  - Sánchez-Díaz, María
AU  - Del Pozo, Natalia
AU  - Martínez de Villarreal, Jaime
AU  - Schweifer, Norbert
AU  - Zagorac, Ivana
AU  - Hilberg, Frank
AU  - Real, Francisco X
PY  - 2023
DO  - 10.1158/1535-7163.MCT-21-0667
UR  - http://hdl.handle.net/20.500.12105/19296
AB  - Bladder cancer is a highly prevalent tumor, requiring the urgent development of novel therapies, especially for locally advanced and metastatic disease. Nintedanib is a potent antifibrotic angio-kinase inhibitor, which has shown clinical efficacy in...
LA  - eng
PB  - American Association for Cancer Research (AACR)
KW  - Lung Neoplasms
KW  - Urinary Bladder Neoplasms
KW  - Humans
KW  - Mice
KW  - Animals
KW  - Phosphatidylinositol 3-Kinases
KW  - Stromal Cells
KW  - Cell Line, Tumor
TI  - Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder Cancer Resistance.
TY  - journal article
ER  -